In this study, we therefore investigate the effects of ART on MDSCs in vitro and in B16F10 and Hepa1-6 in vivo tumor models and determine whether and how targeting MDSCs by ART may enhance anti-PD-L1 immunotherapy. The gene discussed is CD274; the disease is neoplasm.